165 related articles for article (PubMed ID: 20544578)
1. Imaging of brain metastases of bronchial carcinomas with 7 T MRI - initial results.
Mönninghoff C; Maderwald S; Theysohn JM; Schütt P; Gauler T; Kraff O; Ladd ME; Ladd SC; Wanke I
Rofo; 2010 Sep; 182(9):764-72. PubMed ID: 20544578
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study].
Vogl TJ; Friebe CE; Balzer T; Mack MG; Steiner S; Schedel H; Pegios W; Lanksch W; Banzer D; Felix R
Radiologe; 1995 Aug; 35(8):508-16. PubMed ID: 7568795
[TBL] [Abstract][Full Text] [Related]
3. [Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis].
Golfieri R; Cherryman GR; Olliff JF; Husband JE
Radiol Med; 1991; 82(1-2):27-34. PubMed ID: 1654578
[TBL] [Abstract][Full Text] [Related]
4. Intracranial metastases in the initial staging of bronchogenic carcinoma.
Mintz BJ; Tuhrim S; Alexander S; Yang WC; Shanzer S
Chest; 1984 Dec; 86(6):850-3. PubMed ID: 6094117
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
Wang QJ; Wang Y; Xu X; Xiao H; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
[TBL] [Abstract][Full Text] [Related]
6. MR study of N2 disease in lung cancer: contrast-enhanced method using gadolinium-DTPA.
Crisci R; Di Cesare E; Lupattelli L; Coloni GF
Eur J Cardiothorac Surg; 1997 Feb; 11(2):214-7. PubMed ID: 9080145
[TBL] [Abstract][Full Text] [Related]
7. [Detectability of metastatic brain tumors using gadoteridol-enhanced MRI: usefulness of standard-dose T1-weighted spin-echo image with magnetization transfer and enhanced FLAIR].
Annoura K; Utsunomiya H; Arai S; Okazaki M
Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Mar; 60(3):77-82. PubMed ID: 10741113
[TBL] [Abstract][Full Text] [Related]
8. A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours.
Colosimo C; Knopp MV; Barreau X; Gérardin E; Kirchin MA; Guézénoc F; Lodemann KP
Neuroradiology; 2004 Aug; 46(8):655-65. PubMed ID: 15205859
[TBL] [Abstract][Full Text] [Related]
9. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
[TBL] [Abstract][Full Text] [Related]
10. High spatial resolution and high contrast visualization of brain arteries and veins: impact of blood pool contrast agent and water-selective excitation imaging at 3T.
Spuentrup E; Jacobs JE; Kleimann JF; Wiethoff AJ; Poggenborg J; Brinker G; Loehr M; Möller-Hartmann W; Botnar RM; Ernestus RI; Lackner KJ
Rofo; 2010 Dec; 182(12):1097-104. PubMed ID: 20803412
[TBL] [Abstract][Full Text] [Related]
11. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
[TBL] [Abstract][Full Text] [Related]
12. Haemorrhage detection in brain metastases of lung cancer patients using magnetic resonance imaging.
Zhang W; Ma XX; Ji YM; Kang XS; Li CF
J Int Med Res; 2009; 37(4):1139-44. PubMed ID: 19761696
[TBL] [Abstract][Full Text] [Related]
13. Difference in enhancement between spin echo and 3-dimensional fast spoiled gradient recalled acquisition in steady state magnetic resonance imaging of brain metastasis at 3-T magnetic resonance imaging.
Furutani K; Harada M; Mawlan M; Nishitani H
J Comput Assist Tomogr; 2008; 32(2):313-9. PubMed ID: 18379324
[TBL] [Abstract][Full Text] [Related]
14. Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study.
Earnest F; Ryu JH; Miller GM; Luetmer PH; Forstrom LA; Burnett OL; Rowland CM; Swensen SJ; Midthun DE
Radiology; 1999 Apr; 211(1):137-45. PubMed ID: 10189463
[TBL] [Abstract][Full Text] [Related]
15. [Use of contrast agent in high-field MRI (3 T)].
Trattnig S; Ba-Ssalamah A; Nöbauer-Huhmann IM; Barth M; Pinker K; Mlynarik V
Radiologe; 2004 Jan; 44(1):56-64. PubMed ID: 14740095
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging and computed tomography in the diagnoses of brain metastases of lung cancer.
Suzuki K; Yamamoto M; Hasegawa Y; Ando M; Shima K; Sako C; Ito G; Shimokata K
Lung Cancer; 2004 Dec; 46(3):357-60. PubMed ID: 15541821
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla.
Fries P; Morr D; Müller A; Lux F; Tillement O; Massmann A; Seidel R; Schäfer T; Menger MD; Schneider G; Bücker A
Rofo; 2015 Dec; 187(12):1108-15. PubMed ID: 26361379
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility-weighted imaging of the brain: does gadolinium administration matter?
El-Koussy M; Schenk P; Kiefer C; Osman OM; Mordasini P; Ozdoba C; Schroth G; Gönner F
Eur J Radiol; 2012 Feb; 81(2):272-6. PubMed ID: 21216124
[TBL] [Abstract][Full Text] [Related]
19. Staging non-small cell lung cancer with whole-body PET.
Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
[TBL] [Abstract][Full Text] [Related]
20. Comparison between two separate injections and a single injection of double-dose contrast medium for contrast-enhanced MR imaging of metastatic brain tumors.
Ochi T; Taoka T; Matsuda R; Sakamoto M; Akashi T; Tamamoto T; Sugimoto T; Sakaguchi H; Hasegawa M; Nakase H; Kichikawa K
Magn Reson Med Sci; 2014; 13(4):221-9. PubMed ID: 25167875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
